Related Experiment Videos
Cytokines and the Koch phenomenon
1Department of Medical Microbiology, University College and Middlesex School of Medicine, London, UK.
Summary
The Koch phenomenon, or rapid necrosis after mycobacterial antigen injection in tuberculosis patients, is likely due to dysregulated cytokine release, particularly Tumour Necrosis Factor (TNF). Immunotherapy may correct this immune abnormality.
Area of Science:
- Immunology
- Pathology
- Microbiology
Background:
- The Koch phenomenon is defined as necrosis within 24-48 hours of injecting mycobacterial antigen into the skin of tuberculosis patients.
- Similar tissue damage may occur within tuberculosis lesions themselves.
Purpose of the Study:
- To outline the mechanisms contributing to the human form of the Koch phenomenon.
- To investigate the role of cytokines, specifically Tumour Necrosis Factor (TNF), in mediating this necrosis.
- To explore potential therapeutic strategies targeting the associated immunoregulatory abnormality.
Main Methods:
- The study outlines proposed mechanisms based on existing knowledge of immune responses to Mycobacterium tuberculosis.
- It discusses the role of immunoregulatory abnormalities, such as raised agalactosyl IgG, in cytokine dysregulation.
- It examines how Mycobacterium tuberculosis components may distort the protective role of TNF, rendering it toxic.
Main Results:
- Necrosis in the Koch phenomenon is suggested to be mediated partly by cytokines, particularly TNF.
- Mycobacterium tuberculosis induces an immunoregulatory abnormality (raised agalactosyl IgG) linked to cytokine release dysregulation.
- Components of Mycobacterium tuberculosis can distort TNF's function, making it toxic to host tissues.
Conclusions:
- The Koch phenomenon involves cytokine-mediated necrosis, with TNF playing a significant role.
- An underlying immunoregulatory abnormality in tuberculosis patients contributes to this cytokine dysregulation.
- Immunotherapy may offer a potential treatment to correct this immunoregulatory abnormality.